Nebulization of Low-Dose S-Nitrosoglutathione in Diabetic Stroke Enhances Benefits of Reperfusion and Prevents Post-Thrombolysis Hemorrhage

The COVID-19 pandemic has escalated the occurrence of hypoxia including thrombotic stroke worldwide, for which nitric oxide (NO) therapy seems very promising and translatable. Therefore, various modes/routes of NO-delivery are now being tested in different clinical trials for safer, faster, and more...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaidi, Syed Kashif, Ahmed, Farid, Alkhatabi, Heba, Hoda, Md Nasrul, Al-Qahtani, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615482/
https://www.ncbi.nlm.nih.gov/pubmed/34827584
http://dx.doi.org/10.3390/biom11111587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615482/
https://www.ncbi.nlm.nih.gov/pubmed/34827584
http://dx.doi.org/10.3390/biom11111587

Ejemplares similares